Translational progress on tumor biomarkers

There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hongwei, Zhou, Xiaolin, Lu, Yi, Xie, Liye, Chen, Qian, Keller, Evan T, Liu, Qian, Zhou, Qinghua, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632916/
https://www.ncbi.nlm.nih.gov/pubmed/26557902
http://dx.doi.org/10.1111/1759-7714.12294
_version_ 1782399117729726464
author Guo, Hongwei
Zhou, Xiaolin
Lu, Yi
Xie, Liye
Chen, Qian
Keller, Evan T
Liu, Qian
Zhou, Qinghua
Zhang, Jian
author_facet Guo, Hongwei
Zhou, Xiaolin
Lu, Yi
Xie, Liye
Chen, Qian
Keller, Evan T
Liu, Qian
Zhou, Qinghua
Zhang, Jian
author_sort Guo, Hongwei
collection PubMed
description There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been addressed in cancer biology, particularly in the identification and characterization of novel tumor biomarkers. This review focuses on the recent achievements and clinical application prospects in tumor biomarkers based on translational medicine.
format Online
Article
Text
id pubmed-4632916
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46329162015-11-10 Translational progress on tumor biomarkers Guo, Hongwei Zhou, Xiaolin Lu, Yi Xie, Liye Chen, Qian Keller, Evan T Liu, Qian Zhou, Qinghua Zhang, Jian Thorac Cancer Invited Review There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been addressed in cancer biology, particularly in the identification and characterization of novel tumor biomarkers. This review focuses on the recent achievements and clinical application prospects in tumor biomarkers based on translational medicine. John Wiley & Sons, Ltd 2015-11 2015-07-27 /pmc/articles/PMC4632916/ /pubmed/26557902 http://dx.doi.org/10.1111/1759-7714.12294 Text en © 2015 The Authors. Thoracic Cancer published by China Lung Oncology Group and Wiley Publishing Asia Pty Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Invited Review
Guo, Hongwei
Zhou, Xiaolin
Lu, Yi
Xie, Liye
Chen, Qian
Keller, Evan T
Liu, Qian
Zhou, Qinghua
Zhang, Jian
Translational progress on tumor biomarkers
title Translational progress on tumor biomarkers
title_full Translational progress on tumor biomarkers
title_fullStr Translational progress on tumor biomarkers
title_full_unstemmed Translational progress on tumor biomarkers
title_short Translational progress on tumor biomarkers
title_sort translational progress on tumor biomarkers
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632916/
https://www.ncbi.nlm.nih.gov/pubmed/26557902
http://dx.doi.org/10.1111/1759-7714.12294
work_keys_str_mv AT guohongwei translationalprogressontumorbiomarkers
AT zhouxiaolin translationalprogressontumorbiomarkers
AT luyi translationalprogressontumorbiomarkers
AT xieliye translationalprogressontumorbiomarkers
AT chenqian translationalprogressontumorbiomarkers
AT kellerevant translationalprogressontumorbiomarkers
AT liuqian translationalprogressontumorbiomarkers
AT zhouqinghua translationalprogressontumorbiomarkers
AT zhangjian translationalprogressontumorbiomarkers

Ejemplares similares